Showing results (61-70 of 438) with videos related to

Sort By:
Pageof 44
The American Journal of Medicine|August 30, 2008
Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarctionTracy Y Wang, Anita Y Chen, Karen P Alexander, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 23, 2008
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromesUptal D Patel, Fang-Shu Ou, E Magnus Ohman, et al.
Journal of the American College of Cardiology|April 26, 2008
Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialFrederick Feit, Steven V Manoukian, Ramin Ebrahimi, et al.
European Heart Journal|March 21, 2008
Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiativeTracy Y Wang, Anita Y Chen, Eric D Peterson, et al.
Cardiology Journal|August 6, 2013
Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III TrialEric S Williams, Vivian P Thompson, Karen E Chiswell, et al.
American Heart Journal|September 20, 2015
High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fractionMelissa A Daubert, Joseph Massaro, Lawrence Liao, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 23, 2019
Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapiesGuillaume Marquis-Gravel, Michel Zeitouni, Ajar Kochar, et al.
American Heart Journal|November 9, 2016
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart diseaseRobert C Welsh, Matthew T Roe, Philippe Gabriel Steg, et al.
The American Journal of Cardiology|June 18, 2013
Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial)Sreekanth Vemulapalli, Yi Zhou, Matthias Gutberlet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2007
Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophilsGuohong Li, Alison C Keenan, Justin C Young, et al.
Pageof 44